Intellectual Property Rights Provisional Patent filed for AntiCoagulant Buccal Spray Further Patents under Filing

Breaking Boundaries in Pharmaceutical Innovation: Introducing Our Anticoagulant Buccal Spray

At Thercentric Innovations, we are thrilled to unveil our latest pharmaceutical breakthrough – an Anticoagulant Buccal Spray. This cutting-edge product is designed to redefine anticoagulation therapy, offering a revolutionary approach to administration and patient experience.

Key Features of Our Anticoagulant Buccal Spray:

1. Innovative Delivery: Our buccal spray provides a novel and convenient method of delivering anticoagulant medication. By administering the drug through the buccal mucosa, we aim to enhance absorption and ensure rapid onset of action.

2. Patient-Centric Design: We prioritize the patient experience. The buccal spray formulation offers a user-friendly, non-invasive alternative to traditional anticoagulant delivery methods, contributing to improved patient compliance and overall treatment outcomes.

3. Precision and Efficacy: Our formulation is engineered for optimal precision in dosage delivery, ensuring efficacy while minimizing potential side effects. This meticulous approach is central to our commitment to advancing patient care.

Intellectual Property Protection

We take pride in announcing that we have taken significant steps to protect our groundbreaking innovation. A Provisional Patent has been successfully filed for our Anticoagulant Buccal Spray, securing the intellectual property rights associated with this transformative pharmaceutical product.

Unlocking Value in Healthcare: Introducing Our Value Added Generics Portfolio

Thercentric Innovations is excited to announce our focus on Value Added Generics – a commitment to providing cost-effective pharmaceutical solutions without compromising quality or innovation. We have identified four key products within this category that embody our dedication to value creation and patient well-being.

Scroll to Top